Literature DB >> 3462700

Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent.

C Locht, B Chesebro, R Race, J M Keith.   

Abstract

The prion protein (PrP) is a scrapie-associated fibril protein that accumulates in the brains of hamsters and mice infected with the scrapie agent, and also in the brains of persons affected with kuru or Creutzfeldt-Jakob disease. It has been previously proposed that PrP could be either the primary transmissible agent of scrapie or a secondary component involved in the pathogenesis of scrapie. At present, the second possibility seems more likely, for the PrP-specific mRNA is present in both infected and uninfected brains. We have isolated and sequenced the complete PrP-specific cDNA from mRNA isolated from infected mouse brains. Comparison of the mouse PrP with the hamster PrP reveals a high homology in the amino acid sequence and the presence of a conserved octapeptide repeated four times, whose function is unknown at present. Structural features are discussed and compared with other proteins. Except for its homology with the hamster PrP, mouse PrP has no significant homology to any known protein sequence, including neurofilaments, neuropeptides, and amyloid proteins of Alzheimer disease. Some features of the PrP, however, are similar to structures found in aggregating proteins, such as the wheat glutenin, keratin, and collagen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462700      PMCID: PMC386505          DOI: 10.1073/pnas.83.17.6372

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  EXPERIMENTAL TRANSMISSION OF MOUSE PASSAGED SCRAPIE TO GOATS, SHEEP, RATS AND HAMSTERS.

Authors:  I ZLOTNIK; J C RENNIE
Journal:  J Comp Pathol       Date:  1965-04       Impact factor: 1.311

2.  Encephalopathy in mice produced by inoculation with scrapie brain material.

Authors:  R L CHANDLER
Journal:  Lancet       Date:  1961-06-24       Impact factor: 79.321

3.  Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils.

Authors:  G G Glenner; E D Eanes; H A Bladen; R P Linke; J D Termine
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

4.  Susceptibility of mink to sheep scrapie.

Authors:  R P Hanson; R J Eckroade; R F Marsh; G M Zu Rhein; C L Kanitz; D P Gustafson
Journal:  Science       Date:  1971-05-21       Impact factor: 47.728

5.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

Review 6.  Biochemical evolution.

Authors:  A C Wilson; S S Carlson; T J White
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

7.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 9.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  49 in total

1.  Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.

Authors:  J Chabry; S A Priola; K Wehrly; J Nishio; J Hope; B Chesebro
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.

Authors:  B Caughey; G J Raymond; S A Priola; D A Kocisko; R E Race; R A Bessen; P T Lansbury; B Chesebro
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

3.  Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.

Authors:  S A Priola; J Chabry; K Chan
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 5.  Prion amyloid structure explains templating: how proteins can be genes.

Authors:  Reed B Wickner; Frank Shewmaker; Herman Edskes; Dmitry Kryndushkin; Julie Nemecek; Ryan McGlinchey; David Bateman; Chia-Lin Winchester
Journal:  FEMS Yeast Res       Date:  2010-12       Impact factor: 2.796

Review 6.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

Review 7.  Neurodegenerative Disease Transmission and Transgenesis in Mice.

Authors:  Brittany N Dugger; Daniel P Perl; George A Carlson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

8.  Prion protein glycosylation is not required for strain-specific neurotropism.

Authors:  Justin R Piro; Brent T Harris; Koren Nishina; Claudio Soto; Rodrigo Morales; Judy R Rees; Surachai Supattapone
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.

Authors:  Joëlle Chabry; Christiane Ratsimanohatra; Isabelle Sponne; Pierre-Paul Elena; Jean-Pierre Vincent; Thierry Pillot
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

10.  Detection of species specific epitopes of mouse and hamster prion proteins (PrPs) by anti-peptide antibodies.

Authors:  T Yokoyama; S Itohara; N Yuasa
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.